A novel machine learning-derived four-gene signature predicts STEMI and post-STEMI heart failure

Authors

  • Jialu Yao Department of Cardiology, the First Affiliated Hospital of Soochow University, Suzhou, China; Department of Cardiology, Dushu Lake Hospital Affiliated to Soochow University, Medical Center of Soochow University, Institute for Hypertension of Soochow University, Jiangsu Engineering Laboratory of Novel Functional Polymeric Materials of Soochow University, Suzhou, Jiangsu Province, China
  • Yujia Zhou Center for Systems Biology, Department of Bioinformatics, School of Biology and Basic Medical Sciences, Soochow University, Suzhou, China; Suzhou Medical College of Soochow University, Suzhou, Jiangsu Province, China
  • Zhichao Yao Department of Vascular Surgery, Gusu School of Nanjing Medical University, Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital (HQ), Suzhou, Jiangsu Province, China
  • Ye Meng Center for Systems Biology, Department of Bioinformatics, School of Biology and Basic Medical Sciences, Soochow University, Suzhou, China; Suzhou Medical College of Soochow University, Suzhou, Jiangsu Province, China
  • Wangjianfei Yu Center for Systems Biology, Department of Bioinformatics, School of Biology and Basic Medical Sciences, Soochow University, Suzhou, China; Suzhou Medical College of Soochow University, Suzhou, Jiangsu Province, China
  • Xinyu Yang Center for Systems Biology, Department of Bioinformatics, School of Biology and Basic Medical Sciences, Soochow University, Suzhou, China; Suzhou Medical College of Soochow University, Suzhou, Jiangsu Province, China
  • Dayong Zhou Department of Vascular Surgery, Gusu School of Nanjing Medical University, Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital (HQ), Suzhou, Jiangsu Province, China
  • Xiaoqin Yang Department of Cardiology, Dushu Lake Hospital Affiliated to Soochow University, Medical Center of Soochow University, Institute for Hypertension of Soochow University, Jiangsu Engineering Laboratory of Novel Functional Polymeric Materials of Soochow University, Suzhou, Jiangsu Province, China; Center for Systems Biology, Department of Bioinformatics, School of Biology and Basic Medical Sciences, Soochow University, Suzhou, China; Suzhou Medical College of Soochow University, Suzhou, Jiangsu Province, China
  • Yafeng Zhou Department of Cardiology, Dushu Lake Hospital Affiliated to Soochow University, Medical Center of Soochow University, Institute for Hypertension of Soochow University, Jiangsu Engineering Laboratory of Novel Functional Polymeric Materials of Soochow University, Suzhou, Jiangsu Province, China

DOI:

https://doi.org/10.17305/bb.2023.9629

Keywords:

ST-elevation myocardial infarction, heart failure, monocyte, machine learning, prediction model

Abstract

High mortality and morbidity rates associated with ST-elevation myocardial infarction (STEMI) and post-STEMI heart failure (HF) necessitate proper risk stratification for coronary artery disease (CAD). A prediction model that combines specificity and convenience is highly required. This study aimed to design a monocyte-based gene assay for predicting STEMI and post-STEMI HF. A total of 1,956 monocyte expression profiles and corresponding clinical data were integrated from multiple sources. Meta-results were obtained through the weighted gene co-expression network analysis (WGCNA) and differential analysis to identify characteristic genes for STEMI. Machine learning models based on the decision tree (DT), support vector machine (SVM), and random forest (RF) algorithms were trained and validated. Five genes overlapped and were subjected to the model proposal. The discriminative performance of the DT model outperformed the other two methods. The established four-gene panel (HLA-J, CFP, STX11, and NFYC) could discriminate STEMI and HF with an area under the curve (AUC) of 0.86 or above. In the gene set enrichment analysis (GSEA), several cardiac pathogenesis pathways and cardiovascular disorder signatures showed statistically significant, concordant differences between subjects with high and low expression levels of the four-gene panel, affirming the validity of the established model. In conclusion, we have developed and validated a model that offers the hope for accurately predicting the risk of STEMI and HF, leading to optimal risk stratification and personalized management of CAD, thereby improving individual outcomes.

Downloads

Download data is not yet available.
A novel machine-learning-derived four-gene signature predicts STEMI and post-STEMI heart failure

Downloads

Published

11-03-2024

Issue

Section

Translational and Clinical Research

Categories

How to Cite

1.
A novel machine learning-derived four-gene signature predicts STEMI and post-STEMI heart failure. Biomol Biomed [Internet]. 2024 Mar. 11 [cited 2024 May 23];24(2):423–433. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/9629